ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy ...

Of 34 CMML treatment-naïve participants enrolled and treated with lenzilumab plus azacitidine, 22 have evaluable responses in the first twelve months of follow-up - Building upon previously reported ...

Studies indicate that children living near oil and gas wells have a significantly higher risk of developing acute lymphocytic leukemia, prompting calls for better regulations and health protections.

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...

A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...

Mild CMV reactivation was associated with beneficial effects, while severe cases required treatment, which increased the risk of toxicity and infections.

Royal Victoria Infirmary patient Olli Spiller is cycling 30km on an exercise bike to raise awareness of the need for blood ...

Corrina Walters, from Kirkham, Lancashire, who was battling chemo claimed she forked out £1,300 on a wig while undergoing treatment - only for the 'disgusting' wigmaker to 'vanish' ...

The television community is mourning the recent deaths of two prominent figures: Food Network star and longtime host of Worst ...

Gaining insights into the complex pathways and key cell populations involved in immune dysregulation can aid the development ...

A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...

Staff at a hospital Trust have been nominating teams and individuals for Moving to Excellence awards for those who have made ...